ArticlePloS one2026
Maternal early warning system (MEWS) model for predicting and reducing severe maternal outcomes in Ethiopia.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMaternal mortality in Ethiopia remains high, while most of these deaths are preventable. Early detection of deterioration and prompt response are essential to reduce these preventable deaths. The Maternal Early Warning System (MEWS) is a reliable clinical tool for this purpose. However, its effectiveness is underexplored and its bedside use is inconsistent. This study evaluated the MEWS model for predicting and reducing severe maternal outcomes.
methodA parallel, quasi-experimental study design was conducted among 1138 obstetric inpatients at four public hospitals of North Shewa Zone, Ethiopia. The recruitment period was from 05/05/2025-31/8/2025. The intervention group (n = 569) was monitored using the MEWS chart, which included vital signs, oxygen saturation, urine output, consciousness, and pain, and for the postpartum women; vaginal bleeding, uterine contraction, and perineal tear, were categorized as Green, Yellow, or Red. The control group (n = 569) received the standard clinical monitoring. A multivariate generalized estimating equation (GEE) model with Poisson regression was used to compare the outcomes and estimate adjusted risk ratios (aRR) with 95% confidence intervals.
resultThe mean duration from admission to the first trigger was shorter by 4.7 hours (5.61 vs. 10.27 hours), trigger to physician evaluation by 22.6 minutes (49.3 vs. 71.9 minutes), and trigger to clinical intervention by 11.3 minutes (14.6 vs. 25.9 minutes) among women in the intervention group. Women also underwent fewer ultrasound scans (1.32 vs. 2.30) and had a shorter hospital stay by about 0.5 days (4.83 vs. 5.29 days). Women monitored with the MEWS chart had a 20% lower risk of severe maternal outcomes (aRR = 0.85, 95% CI: 0.73-0.99). Additionally, MEWS-monitored women were 9% more likely to be triggered for timely clinical response (aRR = 1.15, 95% CI: 1.03-1.28).
conclusionImplementation of the MEWS was associated with earlier detection of maternal deterioration, shorter clinical response, fewer ultrasound investigations, shorter hospital stays, and lower severe maternal outcomes. Further studies with larger number of clusters are needed to evaluate the effectiveness of MEWS across different risk groups and settings.
trial registrationPan African Clinical Trial Registry (PACTR), PACTR202506739780428, https://pactr.samrc.ac.za.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.